pharma

"The sweeping collaboration will see OpenAI’s intelligent agents embedded across the drug maker’s workflows in order to enhance everything from lab-based drug discovery to the complexities [of drug delivery]"

"This time, we are using KokushiMD-10, a preprint released in June 2025, which organizes 10 types of Japanese national examinations in medical and related fields as an evaluation dataset for LLMs."

"What we truly focus on is not just writing a single document faster, but how this chain of evidence can be organized more efficiently and accurately."

"From those 15 million candidates, the team synthesised roughly 60 in the laboratory. They arrived at a promising scaffold now moving forward for further optimisation."

"The transaction's core is a preclinical oral GLP-1 drug; in addition, based on Insilico Medicine's Pharma AI technology platform, the two parties will also conduct a number of research and development collaborations 'around targets selected by Lilly'."

"=== QAOA drug optimization results ==="

"Eli Lilly will pay Insilico Medicine $115 million upfront, with the remaining payments tied to subsequent regulatory approvals and commercialization progress."

"Insilico Medicine and Eli Lilly sign a drug co-development deal worth up to $2.75B, with $115M in upfront payments"

""Agent能够高度整合各种AI模块，并与人类进行深度协同。 更关键的是，它在进行决策时，能够将前端证据收集、中端假设生成、及后端未来结果模拟，全部纳入当前的决策闭环。""

"With an aging population and medical needs increasing, medical device manufacturers and pharmaceutical companies will benefit from this trend."

"The Zurich-based startup... has secured a larger round to build AI agents that actively manage the complex operational layer of running a clinical trial."

"Earendil Labs, a cutting-edge AI-driven pharmaceutical company spun out from Tsinghua University, is preparing for an IPO on the Hong Kong Stock Exchange."

"Roche's rollout of thousands of Nvidia chips is the latest example of a pharmaceutical giant trying to use AI to discover and manufacture new therapies faster."

"AI is changing the pharmaceutical industry, and the question is no longer whether it can, but how strong its disruptive power will be."

"In the context of this, domestic AI pharmaceutical platform company Crystalgen Holdings announced a profit forecast for 2025: revenue increased to no less than 780 million yuan, an increase of at least 193% year-on-year; after-tax profit and profit attributable to the company's equity holders were no less than 100 million yuan, turning a loss into a profit year-on-year, and achieving annual profit for the first time, also becoming the first AI application stock in Hong Kong to achieve profit."

"EQUES will introduce experimental results and the latest papers."

"Operating on the design principle of ``free-form reasoning for safe tasks, structured execution for long-horizon pipelines,'' Mozi provides built-in robustness mechanisms and trace-level audibility to completely mitigate error accumulation."

"QAI Checker is a system that uses AI to read multiple documents, such as approval documents and manufacturing procedure manuals, and automatically identifies discrepancies in numbers, omissions in processes, and inconsistencies in expressions."

"“We are going to prove to the world that AI can truly deliver on its promise in drug development.”"

"AI is attempting to shed light on the darkness."

"The goal is to reduce the creation of regulatory documents by up to 50% using Generative AI."

"NVIDIA Blackwell Ultra Delivers up to 50x Better Performance and 35x Lower Costs for Agentic AI"

"Experiments on synthetic datasets show that the framework reduces physiological violation rates from 2.00% to 0.50% under constraints while offering a path to faster simulation."

"Kimi K2.5 did much better (albeit still not great)."

"A partnership between Absci, AMD and Oracle is delivering promising results in closing the gap between the rate of drug discovery and bacterial/viral resistance."

"MOLCURE is tackling the structural challenges of drug discovery by leveraging its own AI foundation."

"This system is not about finding 'effective drugs'. It is about presenting 'candidates worth investigating'."